TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$4.50
-0.02 (-0.44%)
As of Apr 1, 3:31 PM ET ·
Financial Highlights (FY 2025)
Revenue
26.00M
Net Income
-3,802,417
Gross Margin
56.7%
Profit Margin
-14.6%
Rev Growth
+20.6%
D/E Ratio
0.27
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.7% 56.7% 56.7%
Operating Margin -17.2% -17.8% -16.2%
Profit Margin -14.6% -17.4% -13.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 26.00M 22.93M 28.87M
Gross Profit 14.75M 13.01M 16.38M
Operating Income -4,473,779 -4,087,425 -4,691,532
Net Income -3,802,417 -3,978,629 -3,915,216
Gross Margin 56.7% 56.7% 56.7%
Operating Margin -17.2% -17.8% -16.2%
Profit Margin -14.6% -17.4% -13.6%
Rev Growth +20.6% +0.2% +12.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.20M 6.25M 6.38M
Total Equity 22.67M 21.99M 21.09M
D/E Ratio 0.27 0.28 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -5,256,206 -4,739,765 -5,087,055
Free Cash Flow -3,224,852 -2,115,724 -2,331,954